

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 8.67096152 |
| 2 | interferon-gamma production (GO:0032609) | 7.75222335 |
| 3 | response to muramyl dipeptide (GO:0032495) | 7.20336638 |
| 4 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 7.16972252 |
| 5 | embryonic process involved in female pregnancy (GO:0060136) | 6.72567504 |
| 6 | response to interleukin-15 (GO:0070672) | 6.55510685 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.48134682 |
| 8 | negative regulation of cell killing (GO:0031342) | 6.43183905 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.43183905 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 6.33799934 |
| 11 | negative regulation of bone resorption (GO:0045779) | 6.13033011 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.85409688 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 5.84220977 |
| 14 | regulation of chronic inflammatory response (GO:0002676) | 5.74939083 |
| 15 | negative regulation of interleukin-1 beta production (GO:0032691) | 5.53105850 |
| 16 | negative T cell selection (GO:0043383) | 5.49869248 |
| 17 | positive thymic T cell selection (GO:0045059) | 5.45496105 |
| 18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.40774501 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 5.31172977 |
| 20 | positive T cell selection (GO:0043368) | 5.19292772 |
| 21 | negative thymic T cell selection (GO:0045060) | 5.19006470 |
| 22 | endothelial cell chemotaxis (GO:0035767) | 4.96016127 |
| 23 | negative regulation of bone remodeling (GO:0046851) | 4.94409955 |
| 24 | thymic T cell selection (GO:0045061) | 4.86692833 |
| 25 | protein K11-linked deubiquitination (GO:0035871) | 4.83899067 |
| 26 | T cell selection (GO:0045058) | 4.77089762 |
| 27 | regulation of germinal center formation (GO:0002634) | 4.75238718 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.70029619 |
| 29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.48893851 |
| 30 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.45143776 |
| 31 | T-helper cell differentiation (GO:0042093) | 4.39978995 |
| 32 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.39978995 |
| 33 | negative regulation of interleukin-1 production (GO:0032692) | 4.39528557 |
| 34 | negative regulation of innate immune response (GO:0045824) | 4.20556680 |
| 35 | negative regulation of tissue remodeling (GO:0034104) | 4.14090195 |
| 36 | alpha-beta T cell differentiation (GO:0046632) | 4.13931392 |
| 37 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 4.02480883 |
| 38 | alpha-beta T cell activation (GO:0046631) | 4.00876668 |
| 39 | T cell receptor signaling pathway (GO:0050852) | 3.99917451 |
| 40 | T cell differentiation involved in immune response (GO:0002292) | 3.93328564 |
| 41 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.93328564 |
| 42 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.93328564 |
| 43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.92472824 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.92472824 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.91102828 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.91102828 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.91102828 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 3.91102828 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 3.91102828 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.91102828 |
| 51 | T cell migration (GO:0072678) | 3.84373522 |
| 52 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.81242303 |
| 53 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.81227659 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 3.80457633 |
| 55 | trophectodermal cell differentiation (GO:0001829) | 3.75971155 |
| 56 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.73793423 |
| 57 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.73498120 |
| 58 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.73227527 |
| 59 | response to peptidoglycan (GO:0032494) | 3.69334755 |
| 60 | regulation of response to interferon-gamma (GO:0060330) | 3.63625292 |
| 61 | B cell homeostasis (GO:0001782) | 3.63535694 |
| 62 | positive regulation of heat generation (GO:0031652) | 3.62524836 |
| 63 | regulation of fever generation (GO:0031620) | 3.62323805 |
| 64 | positive regulation of interleukin-2 production (GO:0032743) | 3.61617995 |
| 65 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.61053485 |
| 66 | mature B cell differentiation involved in immune response (GO:0002313) | 3.59849064 |
| 67 | regulation of T cell tolerance induction (GO:0002664) | 3.58695761 |
| 68 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.56065602 |
| 69 | leukocyte aggregation (GO:0070486) | 3.51295804 |
| 70 | T cell differentiation (GO:0030217) | 3.50577961 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.50498733 |
| 72 | regulation of interleukin-2 production (GO:0032663) | 3.43934293 |
| 73 | regulation of defense response to virus by host (GO:0050691) | 3.42985199 |
| 74 | detection of other organism (GO:0098543) | 3.41997327 |
| 75 | detection of bacterium (GO:0016045) | 3.40438890 |
| 76 | positive regulation of isotype switching (GO:0045830) | 3.39862015 |
| 77 | osteoclast differentiation (GO:0030316) | 3.38092420 |
| 78 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 3.36405760 |
| 79 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.33889461 |
| 80 | negative regulation of interleukin-2 production (GO:0032703) | 3.31740748 |
| 81 | T cell costimulation (GO:0031295) | 3.30412390 |
| 82 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.29702277 |
| 83 | mature B cell differentiation (GO:0002335) | 3.29119359 |
| 84 | neutrophil activation (GO:0042119) | 3.27931353 |
| 85 | lymphocyte costimulation (GO:0031294) | 3.22459894 |
| 86 | regulation of bone resorption (GO:0045124) | 3.21934005 |
| 87 | negative regulation of interleukin-6 production (GO:0032715) | 3.20535063 |
| 88 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.19962004 |
| 89 | regulation of mast cell degranulation (GO:0043304) | 3.19642553 |
| 90 | germinal center formation (GO:0002467) | 3.18457256 |
| 91 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.16416234 |
| 92 | positive regulation of tolerance induction (GO:0002645) | 3.15902291 |
| 93 | entrainment of circadian clock by photoperiod (GO:0043153) | 3.15516555 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 3.14399623 |
| 95 | negative regulation of inclusion body assembly (GO:0090084) | 3.13949284 |
| 96 | lymphocyte homeostasis (GO:0002260) | 3.13141064 |
| 97 | granulocyte activation (GO:0036230) | 3.11644936 |
| 98 | decidualization (GO:0046697) | 3.10269344 |
| 99 | endoderm formation (GO:0001706) | 3.08218133 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 3.06848803 |
| 101 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.05335919 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 3.03633028 |
| 103 | regulation of memory T cell differentiation (GO:0043380) | 3.03287187 |
| 104 | negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124) | 3.02328308 |
| 105 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.99790477 |
| 106 | Peyers patch development (GO:0048541) | 2.99790477 |
| 107 | regulation of thymocyte apoptotic process (GO:0070243) | 2.98739373 |
| 108 | natural killer cell activation (GO:0030101) | 2.98427162 |
| 109 | positive regulation of prostaglandin secretion (GO:0032308) | 2.98259877 |
| 110 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96910944 |
| 111 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.96779634 |
| 112 | response to laminar fluid shear stress (GO:0034616) | 2.91880228 |
| 113 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.88677754 |
| 114 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88344181 |
| 115 | negative regulation of interleukin-8 production (GO:0032717) | 2.87032378 |
| 116 | positive regulation of histone deacetylation (GO:0031065) | 2.86457695 |
| 117 | leukocyte cell-cell adhesion (GO:0007159) | 2.86088081 |
| 118 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.85876864 |
| 119 | response to corticosterone (GO:0051412) | 2.84848814 |
| 120 | T cell activation involved in immune response (GO:0002286) | 2.84676076 |
| 121 | positive regulation of DNA recombination (GO:0045911) | 2.83625611 |
| 122 | protein K48-linked deubiquitination (GO:0071108) | 2.83444180 |
| 123 | myeloid dendritic cell activation (GO:0001773) | 2.82735097 |
| 124 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.80685464 |
| 125 | negative regulation of interleukin-12 production (GO:0032695) | 2.70116839 |
| 126 | response to host (GO:0075136) | 2.68694787 |
| 127 | response to host defenses (GO:0052200) | 2.68694787 |
| 128 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68694787 |
| 129 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.68315395 |
| 130 | response to host immune response (GO:0052572) | 2.68315395 |
| 131 | detection of external biotic stimulus (GO:0098581) | 2.67802963 |
| 132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.66321269 |
| 133 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65054951 |
| 134 | cellular extravasation (GO:0045123) | 2.63856701 |
| 135 | negative regulation of stress fiber assembly (GO:0051497) | 2.63525608 |
| 136 | positive regulation of protein deacetylation (GO:0090312) | 2.61795520 |
| 137 | modulation by virus of host process (GO:0019054) | 2.60131159 |
| 138 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.55775975 |
| 139 | regulation of defense response to virus by virus (GO:0050690) | 2.52288661 |
| 140 | megakaryocyte development (GO:0035855) | 2.52107487 |
| 141 | regulation of regulated secretory pathway (GO:1903305) | 2.50950673 |
| 142 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.48994334 |
| 143 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.47581521 |
| 144 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.47581521 |
| 145 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.47579454 |
| 146 | regulation of necroptotic process (GO:0060544) | 2.44543590 |
| 147 | response to protozoan (GO:0001562) | 2.44247425 |
| 148 | myeloid cell activation involved in immune response (GO:0002275) | 2.44047127 |
| 149 | positive regulation of B cell differentiation (GO:0045579) | 2.43885514 |
| 150 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.42371637 |
| 151 | mannose metabolic process (GO:0006013) | 2.41156036 |
| 152 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.41090631 |
| 153 | modulation by symbiont of host cellular process (GO:0044068) | 2.40824965 |
| 154 | defense response to protozoan (GO:0042832) | 2.39687396 |
| 155 | protein localization to endosome (GO:0036010) | 2.39685555 |
| 156 | response to type I interferon (GO:0034340) | 2.39544295 |
| 157 | regulation of mast cell activation (GO:0033003) | 2.38400884 |
| 158 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.38027731 |
| 159 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.36065344 |
| 160 | type I interferon signaling pathway (GO:0060337) | 2.34341746 |
| 161 | cellular response to type I interferon (GO:0071357) | 2.34341746 |
| 162 | signal complex assembly (GO:0007172) | 2.34053886 |
| 163 | positive regulation of granulocyte differentiation (GO:0030854) | 2.33353564 |
| 164 | detection of biotic stimulus (GO:0009595) | 2.32215628 |
| 165 | stress fiber assembly (GO:0043149) | 2.31672811 |
| 166 | thrombin receptor signaling pathway (GO:0070493) | 2.30707733 |
| 167 | leukocyte degranulation (GO:0043299) | 2.29912361 |
| 168 | hypotonic response (GO:0006971) | 2.28824633 |
| 169 | barbed-end actin filament capping (GO:0051016) | 2.28449223 |
| 170 | negative regulation of myotube differentiation (GO:0010832) | 2.28338200 |
| 171 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.28202547 |
| 172 | positive regulation of mast cell activation (GO:0033005) | 2.28085740 |
| 173 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.26815686 |
| 174 | tolerance induction (GO:0002507) | 10.2918181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.02215814 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.63102574 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.82374034 |
| 4 | * MYC_22102868_ChIP-Seq_BL_Human | 3.93689895 |
| 5 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.63341459 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.59834859 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49734689 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.44376372 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.90818814 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.82201070 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.80476492 |
| 12 | * MYB_26560356_Chip-Seq_TH2_Human | 2.79523564 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.77631125 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.69131607 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68744759 |
| 16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.65590542 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.53814034 |
| 18 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.52194932 |
| 19 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.52170410 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43197620 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40668399 |
| 22 | * MYB_26560356_Chip-Seq_TH1_Human | 2.39747436 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.30586904 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.30401926 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.29428982 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.22838314 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.21916215 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05068301 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.99946689 |
| 30 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96742463 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96708105 |
| 32 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89136212 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87646395 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84831821 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83809752 |
| 36 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.72952219 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71039707 |
| 38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70902905 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69992903 |
| 40 | * MAF_26560356_Chip-Seq_TH2_Human | 1.68953559 |
| 41 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.68842043 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67059589 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66944686 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64847451 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61335019 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59291537 |
| 47 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57857390 |
| 48 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48020803 |
| 49 | P68_20966046_ChIP-Seq_HELA_Human | 1.46671251 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45960564 |
| 51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.45708928 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45464257 |
| 53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.43433372 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.39288739 |
| 55 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38520623 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.36217058 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36031198 |
| 58 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35567443 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32790987 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32721828 |
| 61 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.32105628 |
| 62 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32049805 |
| 63 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26696919 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26527292 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24837488 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23381575 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21059478 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20385049 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19160438 |
| 70 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.19129461 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18094482 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16101906 |
| 73 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14381701 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14376275 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14087043 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13359309 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11604796 |
| 78 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10867744 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09987040 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08407996 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08133672 |
| 82 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.07968615 |
| 83 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.07968615 |
| 84 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.07968615 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07697129 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07515135 |
| 87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06919494 |
| 88 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.06541988 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06064371 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05498640 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05420724 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05281038 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05102770 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03769695 |
| 95 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.03539318 |
| 96 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.03050241 |
| 97 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.02942628 |
| 98 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02647528 |
| 99 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01936516 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01394154 |
| 101 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01246054 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00925457 |
| 103 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.00843167 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00658568 |
| 105 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99892411 |
| 106 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98206052 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97397305 |
| 108 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97116612 |
| 109 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.96347303 |
| 110 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95302445 |
| 111 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94986825 |
| 112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93266519 |
| 113 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.91851137 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90765255 |
| 115 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.90669625 |
| 116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88918945 |
| 117 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87640610 |
| 118 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87415412 |
| 119 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87338845 |
| 120 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87230896 |
| 121 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84920769 |
| 122 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84690853 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82629284 |
| 124 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82290144 |
| 125 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.81904026 |
| 126 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81730009 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80757823 |
| 128 | GATA3_26560356_Chip-Seq_TH2_Human | 0.79888210 |
| 129 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.76432658 |
| 130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76093691 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76093229 |
| 132 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.75680486 |
| 133 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.75247362 |
| 134 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74292392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.81099495 |
| 2 | MP0000685_abnormal_immune_system | 4.50928115 |
| 3 | MP0005671_abnormal_response_to | 3.49657138 |
| 4 | MP0004510_myositis | 3.22005876 |
| 5 | MP0005387_immune_system_phenotype | 3.14211671 |
| 6 | MP0001790_abnormal_immune_system | 3.14211671 |
| 7 | MP0004947_skin_inflammation | 3.10201730 |
| 8 | MP0001800_abnormal_humoral_immune | 3.07561251 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.06805978 |
| 10 | MP0002723_abnormal_immune_serum | 2.72580047 |
| 11 | MP0002405_respiratory_system_inflammati | 2.71898966 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.69995355 |
| 13 | MP0002933_joint_inflammation | 2.55910196 |
| 14 | MP0003724_increased_susceptibility_to | 2.54845540 |
| 15 | MP0003303_peritoneal_inflammation | 2.50518360 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.45393202 |
| 17 | MP0006082_CNS_inflammation | 2.42895597 |
| 18 | MP0001819_abnormal_immune_cell | 2.42424040 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.42053766 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.41814368 |
| 21 | MP0003436_decreased_susceptibility_to | 2.35715114 |
| 22 | MP0002398_abnormal_bone_marrow | 2.29530122 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.23041296 |
| 24 | MP0009785_altered_susceptibility_to | 2.18813425 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.18401079 |
| 26 | MP0000716_abnormal_immune_system | 2.12923794 |
| 27 | MP0001873_stomach_inflammation | 2.10898697 |
| 28 | MP0003300_gastrointestinal_ulcer | 2.02866921 |
| 29 | MP0005451_abnormal_body_composition | 1.96031964 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.94787960 |
| 31 | MP0002722_abnormal_immune_system | 1.89084679 |
| 32 | MP0008961_abnormal_basal_metabolism | 1.88607055 |
| 33 | MP0003866_abnormal_defecation | 1.84027017 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.83763864 |
| 35 | MP0003828_pulmonary_edema | 1.81905681 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.81463611 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.81453228 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.80586080 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.79745633 |
| 40 | MP0005025_abnormal_response_to | 1.79544274 |
| 41 | MP0001851_eye_inflammation | 1.76613286 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.74659589 |
| 43 | MP0008260_abnormal_autophagy | 1.73922662 |
| 44 | MP0002429_abnormal_blood_cell | 1.70254748 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.70172420 |
| 46 | MP0008007_abnormal_cellular_replicative | 1.70079680 |
| 47 | MP0002419_abnormal_innate_immunity | 1.69154530 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.65928745 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.61717196 |
| 50 | MP0009278_abnormal_bone_marrow | 1.60055012 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.59952479 |
| 52 | MP0000858_altered_metastatic_potential | 1.57933482 |
| 53 | MP0001853_heart_inflammation | 1.54987601 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 1.52458980 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.52406137 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.51751661 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.47155827 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.46767804 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.46767804 |
| 60 | MP0004381_abnormal_hair_follicle | 1.46690114 |
| 61 | MP0002006_tumorigenesis | 1.43216992 |
| 62 | MP0008004_abnormal_stomach_pH | 1.39497680 |
| 63 | MP0009764_decreased_sensitivity_to | 1.30962804 |
| 64 | MP0002796_impaired_skin_barrier | 1.30962643 |
| 65 | MP0001542_abnormal_bone_strength | 1.29855106 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.29839049 |
| 67 | MP0004264_abnormal_extraembryonic_tissu | 1.29047371 |
| 68 | MP0000678_abnormal_parathyroid_gland | 1.27752713 |
| 69 | MP0001849_ear_inflammation | 1.26796761 |
| 70 | MP0005083_abnormal_biliary_tract | 1.23726943 |
| 71 | MP0001881_abnormal_mammary_gland | 1.21149460 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 1.19048595 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.18539658 |
| 74 | MP0001243_abnormal_dermal_layer | 1.17864126 |
| 75 | MP0000609_abnormal_liver_physiology | 1.12797826 |
| 76 | MP0005409_darkened_coat_color | 1.10940042 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.07164379 |
| 78 | MP0001502_abnormal_circadian_rhythm | 1.05891251 |
| 79 | MP0004858_abnormal_nervous_system | 1.04524148 |
| 80 | MP0000490_abnormal_crypts_of | 1.03367958 |
| 81 | MP0005501_abnormal_skin_physiology | 1.02765118 |
| 82 | MP0008469_abnormal_protein_level | 1.02584538 |
| 83 | MP0002396_abnormal_hematopoietic_system | 1.00207823 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.98998042 |
| 85 | MP0003448_altered_tumor_morphology | 0.97456795 |
| 86 | MP0002132_abnormal_respiratory_system | 0.95909696 |
| 87 | MP0002060_abnormal_skin_morphology | 0.94656321 |
| 88 | MP0005164_abnormal_response_to | 0.91735068 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.91732922 |
| 90 | MP0001216_abnormal_epidermal_layer | 0.91283165 |
| 91 | MP0002653_abnormal_ependyma_morphology | 0.89843914 |
| 92 | MP0002098_abnormal_vibrissa_morphology | 0.89604908 |
| 93 | MP0003091_abnormal_cell_migration | 0.88090919 |
| 94 | MP0003795_abnormal_bone_structure | 0.87856422 |
| 95 | MP0000681_abnormal_thyroid_gland | 0.86845193 |
| 96 | MP0001191_abnormal_skin_condition | 0.85233867 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.84999794 |
| 98 | MP0005381_digestive/alimentary_phenotyp | 0.84039142 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.82674408 |
| 100 | MP0000470_abnormal_stomach_morphology | 0.80696553 |
| 101 | MP0005310_abnormal_salivary_gland | 0.80496725 |
| 102 | MP0000249_abnormal_blood_vessel | 0.80193815 |
| 103 | MP0004883_abnormal_blood_vessel | 0.80065967 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.79710660 |
| 105 | MP0005390_skeleton_phenotype | 0.78794505 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.78429022 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.77575118 |
| 108 | MP0000604_amyloidosis | 0.77113208 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.75049540 |
| 110 | MP0000343_altered_response_to | 0.74078957 |
| 111 | MP0009763_increased_sensitivity_to | 0.72302014 |
| 112 | MP0002254_reproductive_system_inflammat | 0.71781409 |
| 113 | MP0000733_abnormal_muscle_development | 0.60726757 |
| 114 | MP0003075_altered_response_to | 0.58972520 |
| 115 | MP0003045_fibrosis | 0.56924795 |
| 116 | MP0000367_abnormal_coat/_hair | 0.55486903 |
| 117 | MP0000477_abnormal_intestine_morphology | 0.54847984 |
| 118 | MP0000350_abnormal_cell_proliferation | 0.54757642 |
| 119 | MP0005023_abnormal_wound_healing | 0.54371903 |
| 120 | MP0005166_decreased_susceptibility_to | 0.54338239 |
| 121 | MP0003566_abnormal_cell_adhesion | 0.54259893 |
| 122 | MP0008995_early_reproductive_senescence | 0.53551193 |
| 123 | MP0003077_abnormal_cell_cycle | 0.53398035 |
| 124 | MP0001663_abnormal_digestive_system | 0.52953529 |
| 125 | MP0009931_abnormal_skin_appearance | 0.52891033 |
| 126 | MP0009840_abnormal_foam_cell | 0.51587845 |
| 127 | MP0003329_amyloid_beta_deposits | 0.48161313 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.47583202 |
| 129 | MP0005621_abnormal_cell_physiology | 0.45141436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 8.64340140 |
| 2 | Increased density of long bones (HP:0006392) | 7.58446444 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 6.25451558 |
| 4 | Optic neuritis (HP:0100653) | 6.25451558 |
| 5 | Persistence of primary teeth (HP:0006335) | 6.06913723 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.05978768 |
| 7 | Orchitis (HP:0100796) | 5.71073191 |
| 8 | Myositis (HP:0100614) | 5.70445617 |
| 9 | IgM deficiency (HP:0002850) | 4.89108797 |
| 10 | Keratoconjunctivitis sicca (HP:0001097) | 4.49392692 |
| 11 | Severe combined immunodeficiency (HP:0004430) | 4.38904063 |
| 12 | T lymphocytopenia (HP:0005403) | 4.38713404 |
| 13 | Nasal polyposis (HP:0100582) | 4.20833985 |
| 14 | Abnormality of T cell number (HP:0011839) | 4.13978714 |
| 15 | Keratoconjunctivitis (HP:0001096) | 4.05935137 |
| 16 | IgG deficiency (HP:0004315) | 4.01220792 |
| 17 | Thyroiditis (HP:0100646) | 3.91683721 |
| 18 | Pulmonary infiltrates (HP:0002113) | 3.90654197 |
| 19 | Arterial thrombosis (HP:0004420) | 3.90018939 |
| 20 | Combined immunodeficiency (HP:0005387) | 3.89689505 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.71875035 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.68694948 |
| 23 | Prolonged bleeding time (HP:0003010) | 3.54835297 |
| 24 | Abnormality of T cells (HP:0002843) | 3.53706621 |
| 25 | Abnormality of the nasal mucosa (HP:0000433) | 3.51286011 |
| 26 | Abnormality of eosinophils (HP:0001879) | 3.49126251 |
| 27 | Hemoptysis (HP:0002105) | 3.48685681 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.36707414 |
| 29 | Recurrent abscess formation (HP:0002722) | 3.35563011 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.27900216 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.27809469 |
| 32 | Vasculitis (HP:0002633) | 3.22616088 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 3.08473076 |
| 34 | Petechiae (HP:0000967) | 3.05551149 |
| 35 | Depressed nasal tip (HP:0000437) | 3.04022896 |
| 36 | Eczematoid dermatitis (HP:0000976) | 3.01519713 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.97395678 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.94569995 |
| 39 | Joint swelling (HP:0001386) | 2.92487096 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.92268694 |
| 41 | IgA deficiency (HP:0002720) | 2.92156881 |
| 42 | Leukocytosis (HP:0001974) | 2.91847137 |
| 43 | Pulmonary embolism (HP:0002204) | 2.89500427 |
| 44 | Chronic diarrhea (HP:0002028) | 2.81409553 |
| 45 | Broad face (HP:0000283) | 2.81211319 |
| 46 | Urticaria (HP:0001025) | 2.77077243 |
| 47 | Abnormality of B cell number (HP:0010975) | 2.76111181 |
| 48 | B lymphocytopenia (HP:0010976) | 2.76111181 |
| 49 | Chronic otitis media (HP:0000389) | 2.70813185 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.70268106 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67476044 |
| 52 | Obstructive lung disease (HP:0006536) | 2.67476044 |
| 53 | Cellulitis (HP:0100658) | 2.66680911 |
| 54 | Epistaxis (HP:0000421) | 2.65890818 |
| 55 | Recurrent sinusitis (HP:0011108) | 2.61422861 |
| 56 | Anorexia (HP:0002039) | 2.59937042 |
| 57 | Encephalitis (HP:0002383) | 2.57544635 |
| 58 | Increased IgM level (HP:0003496) | 2.55981579 |
| 59 | Gastrointestinal stroma tumor (HP:0100723) | 2.52225740 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.51490321 |
| 61 | Gangrene (HP:0100758) | 2.50671328 |
| 62 | Premature loss of primary teeth (HP:0006323) | 2.48159895 |
| 63 | Meningitis (HP:0001287) | 2.43015082 |
| 64 | Milia (HP:0001056) | 2.37406144 |
| 65 | Pustule (HP:0200039) | 2.35837133 |
| 66 | Lymphopenia (HP:0001888) | 2.35098663 |
| 67 | Increased IgE level (HP:0003212) | 2.34269911 |
| 68 | Lymphoma (HP:0002665) | 2.32730661 |
| 69 | Abnormality of the fingertips (HP:0001211) | 2.32618683 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.32590742 |
| 71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.32590742 |
| 72 | Recurrent viral infections (HP:0004429) | 2.30298712 |
| 73 | Thick nail (HP:0001805) | 2.29890507 |
| 74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.25212713 |
| 75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25212713 |
| 76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.25212713 |
| 77 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25009838 |
| 78 | Increased serum ferritin (HP:0003281) | 2.24053862 |
| 79 | Emphysema (HP:0002097) | 2.23729836 |
| 80 | Chest pain (HP:0100749) | 2.23646479 |
| 81 | Abnormality of the pericardium (HP:0001697) | 2.23356544 |
| 82 | Abnormality of the nasal septum (HP:0000419) | 2.21880242 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 2.21075952 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 2.19686347 |
| 85 | Eosinophilia (HP:0001880) | 2.19183750 |
| 86 | Malnutrition (HP:0004395) | 2.17876343 |
| 87 | Abnormal platelet volume (HP:0011876) | 2.17563213 |
| 88 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16023215 |
| 89 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.13986614 |
| 90 | Abnormality of the pleura (HP:0002103) | 2.12929427 |
| 91 | Polygenic inheritance (HP:0010982) | 2.11750606 |
| 92 | Obstructive sleep apnea (HP:0002870) | 2.11279349 |
| 93 | Osteomyelitis (HP:0002754) | 2.09429975 |
| 94 | Hypochromic anemia (HP:0001931) | 2.08714939 |
| 95 | Nail dystrophy (HP:0008404) | 2.08010593 |
| 96 | Cerebral aneurysm (HP:0004944) | 2.06245505 |
| 97 | Thrombophlebitis (HP:0004418) | 2.06221506 |
| 98 | Abnormality of the endocardium (HP:0004306) | 2.05915030 |
| 99 | Dysostosis multiplex (HP:0000943) | 2.05554872 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 2.04758924 |
| 101 | Keratitis (HP:0000491) | 2.04607667 |
| 102 | Aortic dissection (HP:0002647) | 2.04523681 |
| 103 | Hepatitis (HP:0012115) | 2.04441187 |
| 104 | Aortic aneurysm (HP:0004942) | 2.04300106 |
| 105 | Easy fatigability (HP:0003388) | 2.03748226 |
| 106 | Hemorrhage of the eye (HP:0011885) | 2.03162327 |
| 107 | Abnormality of the prostate (HP:0008775) | 2.02784525 |
| 108 | Impaired platelet aggregation (HP:0003540) | 2.02332361 |
| 109 | Abnormal platelet function (HP:0011869) | 2.02332361 |
| 110 | Abnormality of nail color (HP:0100643) | 2.02168396 |
| 111 | Abnormal blistering of the skin (HP:0008066) | 2.02066865 |
| 112 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01870201 |
| 113 | Spontaneous hematomas (HP:0007420) | 2.01459122 |
| 114 | Flattened epiphyses (HP:0003071) | 2.01162184 |
| 115 | Purpura (HP:0000979) | 2.00928732 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.99574429 |
| 117 | Glomerulopathy (HP:0100820) | 1.99574082 |
| 118 | Recurrent skin infections (HP:0001581) | 1.99257813 |
| 119 | Pancytopenia (HP:0001876) | 1.96797854 |
| 120 | Mitral valve prolapse (HP:0001634) | 1.93723105 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92520519 |
| 122 | Bronchitis (HP:0012387) | 1.92506194 |
| 123 | Inflammation of the large intestine (HP:0002037) | 1.92401181 |
| 124 | Thin bony cortex (HP:0002753) | 1.91918824 |
| 125 | Arthralgia (HP:0002829) | 1.91619428 |
| 126 | Hypertensive crisis (HP:0100735) | 1.91242697 |
| 127 | Loss of speech (HP:0002371) | 1.90471196 |
| 128 | Hypergammaglobulinemia (HP:0010702) | 1.90387453 |
| 129 | Rhinitis (HP:0012384) | 1.90078318 |
| 130 | Gingival bleeding (HP:0000225) | 1.89126225 |
| 131 | Dilatation of the ascending aorta (HP:0005111) | 1.88810492 |
| 132 | Gastrointestinal inflammation (HP:0004386) | 1.88542313 |
| 133 | Papilloma (HP:0012740) | 1.86881322 |
| 134 | Verrucae (HP:0200043) | 1.86881322 |
| 135 | Abnormal albumin level (HP:0012116) | 1.86525691 |
| 136 | Hypoalbuminemia (HP:0003073) | 1.86525691 |
| 137 | Distal lower limb amyotrophy (HP:0008944) | 1.86277548 |
| 138 | Episodic fever (HP:0001954) | 1.85813847 |
| 139 | Slow saccadic eye movements (HP:0000514) | 1.85556828 |
| 140 | Arterial tortuosity (HP:0005116) | 1.82356662 |
| 141 | Colitis (HP:0002583) | 1.80811388 |
| 142 | Ureteral stenosis (HP:0000071) | 1.80294579 |
| 143 | Gingivitis (HP:0000230) | 1.78863527 |
| 144 | Cheilitis (HP:0100825) | 1.78675848 |
| 145 | Granulocytopenia (HP:0001913) | 1.77227137 |
| 146 | Skin ulcer (HP:0200042) | 1.76943605 |
| 147 | Polyneuropathy (HP:0001271) | 1.76728628 |
| 148 | Deep palmar crease (HP:0006191) | 1.75657679 |
| 149 | Vertebral arch anomaly (HP:0008438) | 1.75558670 |
| 150 | Onion bulb formation (HP:0003383) | 1.75306035 |
| 151 | Diplopia (HP:0000651) | 1.74660614 |
| 152 | Abnormality of binocular vision (HP:0011514) | 1.74660614 |
| 153 | Acrocyanosis (HP:0001063) | 1.74515561 |
| 154 | Hypertriglyceridemia (HP:0002155) | 1.73043382 |
| 155 | Bruising susceptibility (HP:0000978) | 1.72859992 |
| 156 | Difficulty climbing stairs (HP:0003551) | 1.71469935 |
| 157 | Polycythemia (HP:0001901) | 1.70737724 |
| 158 | Plantar hyperkeratosis (HP:0007556) | 1.66531097 |
| 159 | Sepsis (HP:0100806) | 1.66387349 |
| 160 | Menorrhagia (HP:0000132) | 1.65558909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.85421454 |
| 2 | MAP4K1 | 4.44360925 |
| 3 | ITK | 3.98922154 |
| 4 | IRAK3 | 3.37952531 |
| 5 | TAOK3 | 3.30231682 |
| 6 | MAP3K14 | 3.29080201 |
| 7 | PRPF4B | 3.17737147 |
| 8 | EPHA2 | 2.63520426 |
| 9 | TSSK6 | 2.52024870 |
| 10 | GRK6 | 2.49114502 |
| 11 | TBK1 | 2.44419595 |
| 12 | STK10 | 2.37504719 |
| 13 | JAK1 | 2.33674569 |
| 14 | EPHB1 | 2.25998207 |
| 15 | TEC | 2.21050211 |
| 16 | IKBKE | 2.19766619 |
| 17 | RIPK4 | 2.18171683 |
| 18 | JAK3 | 1.97658400 |
| 19 | FGFR4 | 1.95300540 |
| 20 | IKBKB | 1.94153057 |
| 21 | MAP3K10 | 1.93136680 |
| 22 | TYK2 | 1.89926002 |
| 23 | CHUK | 1.88312826 |
| 24 | BTK | 1.84878166 |
| 25 | EPHA3 | 1.83215396 |
| 26 | RPS6KA4 | 1.81076472 |
| 27 | NLK | 1.77764754 |
| 28 | ZAP70 | 1.62144518 |
| 29 | EEF2K | 1.59263945 |
| 30 | TAOK2 | 1.48696340 |
| 31 | TRIB3 | 1.47015221 |
| 32 | PIM1 | 1.44443643 |
| 33 | HCK | 1.43675191 |
| 34 | LMTK2 | 1.36033486 |
| 35 | MST4 | 1.31903722 |
| 36 | TNK2 | 1.30266618 |
| 37 | PKN2 | 1.29478006 |
| 38 | TGFBR2 | 1.27795267 |
| 39 | MARK2 | 1.26756387 |
| 40 | LCK | 1.24732097 |
| 41 | PTK6 | 1.24681284 |
| 42 | MAP3K1 | 1.22902692 |
| 43 | SMG1 | 1.19084071 |
| 44 | MST1R | 1.18451472 |
| 45 | ICK | 1.17523850 |
| 46 | IRAK2 | 1.15678681 |
| 47 | TYRO3 | 1.14280207 |
| 48 | MAP3K13 | 1.13964947 |
| 49 | SIK3 | 1.10218502 |
| 50 | FGFR3 | 1.10159170 |
| 51 | JAK2 | 1.09119714 |
| 52 | MAP2K3 | 1.08662492 |
| 53 | MARK3 | 1.07740619 |
| 54 | MAP3K11 | 0.96728063 |
| 55 | CSK | 0.96018186 |
| 56 | MAPK15 | 0.93558437 |
| 57 | TESK1 | 0.91979210 |
| 58 | MATK | 0.91067904 |
| 59 | EPHB2 | 0.90218568 |
| 60 | RPS6KC1 | 0.87794535 |
| 61 | RPS6KL1 | 0.87794535 |
| 62 | GSK3A | 0.86813618 |
| 63 | TAOK1 | 0.86458110 |
| 64 | RPS6KA2 | 0.83533877 |
| 65 | SYK | 0.83114493 |
| 66 | IRAK1 | 0.83050352 |
| 67 | MELK | 0.82346756 |
| 68 | RPS6KA5 | 0.81842199 |
| 69 | MAP2K2 | 0.81778400 |
| 70 | RPS6KA6 | 0.79576805 |
| 71 | PRKCH | 0.78573428 |
| 72 | LRRK2 | 0.78280418 |
| 73 | CDK12 | 0.78239527 |
| 74 | CDC42BPA | 0.78212058 |
| 75 | PKN1 | 0.77559478 |
| 76 | PRKCQ | 0.75611021 |
| 77 | PDPK1 | 0.75107154 |
| 78 | SIK2 | 0.74386702 |
| 79 | PTK2B | 0.71597365 |
| 80 | RPS6KA1 | 0.70157905 |
| 81 | SIK1 | 0.67230440 |
| 82 | PRKG2 | 0.66371991 |
| 83 | STK38 | 0.66317675 |
| 84 | PRKD3 | 0.66171617 |
| 85 | KSR2 | 0.65874247 |
| 86 | CSF1R | 0.65715361 |
| 87 | HIPK2 | 0.64385221 |
| 88 | PAK4 | 0.64095121 |
| 89 | ERN1 | 0.61950522 |
| 90 | CDK4 | 0.60459915 |
| 91 | MAP3K7 | 0.60219501 |
| 92 | MTOR | 0.56941703 |
| 93 | MAP3K3 | 0.53786061 |
| 94 | PDGFRB | 0.52959998 |
| 95 | ALK | 0.50007803 |
| 96 | IRAK4 | 0.48948261 |
| 97 | NME2 | 0.48032188 |
| 98 | RIPK1 | 0.46769413 |
| 99 | MAPK11 | 0.45547490 |
| 100 | MAP3K6 | 0.45442854 |
| 101 | MAPK7 | 0.44506771 |
| 102 | FGR | 0.43977240 |
| 103 | CLK1 | 0.43364431 |
| 104 | STK11 | 0.42653811 |
| 105 | MOS | 0.41708818 |
| 106 | MAP3K8 | 0.41439493 |
| 107 | FES | 0.41199232 |
| 108 | MAPKAPK5 | 0.41128906 |
| 109 | TESK2 | 0.39208404 |
| 110 | TRPM7 | 0.37634777 |
| 111 | DDR2 | 0.37457590 |
| 112 | DMPK | 0.37195251 |
| 113 | MAP2K6 | 0.37016482 |
| 114 | MAPK12 | 0.36479999 |
| 115 | RET | 0.35862112 |
| 116 | PRKD2 | 0.35485929 |
| 117 | TTN | 0.34220278 |
| 118 | MAPK3 | 0.33263425 |
| 119 | LYN | 0.33150674 |
| 120 | DYRK1B | 0.32803651 |
| 121 | MAPK8 | 0.32099582 |
| 122 | IGF1R | 0.30446911 |
| 123 | BRD4 | 0.29327396 |
| 124 | CDK9 | 0.29183779 |
| 125 | INSR | 0.28109325 |
| 126 | KIT | 0.27335108 |
| 127 | MAPK1 | 0.27136224 |
| 128 | PDK1 | 0.27135233 |
| 129 | PTK2 | 0.25819227 |
| 130 | MAPK4 | 0.25638087 |
| 131 | PIM2 | 0.24655448 |
| 132 | MAPKAPK2 | 0.24194654 |
| 133 | CDK6 | 0.23732574 |
| 134 | BMX | 0.23313116 |
| 135 | STK24 | 0.22210400 |
| 136 | BLK | 0.19023713 |
| 137 | FGFR1 | 0.18467013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 4.13008125 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.62501569 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.47879345 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.45875044 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.40861657 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.77941465 |
| 7 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.57218384 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35847442 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.28154087 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25969468 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.08683260 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.08184020 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05261372 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.91166887 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.87454669 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.84351444 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 1.83225953 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.80824189 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.66486838 |
| 20 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.61008480 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60275453 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.56859042 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.54330986 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.48418804 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42034980 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42027831 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38450798 |
| 28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32973585 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.31774690 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31425116 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31035442 |
| 32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.30297866 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30068144 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.25755186 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.25570971 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23823170 |
| 37 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22344760 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17592431 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16943886 |
| 40 | HTLV-I infection_Homo sapiens_hsa05166 | 1.16264310 |
| 41 | Colorectal cancer_Homo sapiens_hsa05210 | 1.14642337 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13930902 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12590721 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.12329012 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11561353 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07432541 |
| 47 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.04693647 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03884425 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.02437800 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00828864 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99788725 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98832494 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98048476 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91230601 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90065459 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.87908793 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87059956 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.86429027 |
| 59 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83039198 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81379082 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.81009580 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80935824 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80366742 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.75660676 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74898084 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.74074574 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71931122 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70099220 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68301870 |
| 70 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67676679 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.66660135 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64947271 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63549287 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63112644 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63012993 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62940345 |
| 77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61573512 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61394660 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61153390 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.60153427 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58200881 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57899157 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.56459177 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56289920 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.56200676 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55881897 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55696395 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55543206 |
| 89 | * Endocytosis_Homo sapiens_hsa04144 | 0.55266125 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55183908 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.52555675 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52541166 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52327384 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46695309 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44432666 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44356322 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.43351018 |
| 98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42594232 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42527372 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.41968894 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40704712 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40509158 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.40302107 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37723218 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.37235854 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36929270 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36634502 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.35908910 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35760540 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35453700 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34014324 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33451688 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32845834 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32031758 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31348413 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31247935 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29929218 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28759350 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26475059 |

